- Filed
- Jul 16, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 31, 2024 | 42.22M sh |
| Cash And Equivalents | FY 2024 · Mar 31, 2024 | $2.5M |
| Long Term Debt | FY 2024 · Mar 31, 2023 | $10.33M |
| Short Term Debt | FY 2024 · Mar 31, 2023 | $60.64M |
| Current Liabilities | FY 2024 · Mar 31, 2023 | $98.04M |
| Total Liabilities | FY 2024 · Mar 31, 2023 | $117.39M |
| Current Assets | FY 2024 · Mar 31, 2023 | $106.63M |
| Total Assets | FY 2024 · Mar 31, 2023 | $146.68M |
| Shares Diluted | FY 2024 · Mar 31, 2022 | 32.68M sh |
| Capex restated | FY 2024 · Mar 31, 2022 | $3.04M |
| Operating Cash Flow restated | FY 2024 · Mar 31, 2022 | −$7.01M |
| Eps Diluted restated | FY 2024 · Mar 31, 2022 | $0.12 |
| Eps Basic restated | FY 2024 · Mar 31, 2022 | $0.12 |
| Sga Expense restated | FY 2024 · Mar 31, 2022 | $36.42M |
| Net Income restated | FY 2024 · Mar 31, 2022 | $3.92M |
| Operating Income restated | FY 2024 · Mar 31, 2022 | $7.29M |
| Revenue restated | FY 2024 · Mar 31, 2022 | $234.75M |
| Stockholders Equity restated | FY 2024 · Mar 31, 2021 | $20.3M |